FDA Issues Draft Guidance for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions

Start
The US Food and Drug Administration (FDA or the Agency) recently issued its draft guidance titled “Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions.”…
By: Goodwin
Previous Story

HealthPlan Services, Inc. Files Notice of Data Breach Impacting Thousands

Next Story

Public consultation on binding rules for phone marketing – Spanish update